Centre Testing International Group (300012) Q4 2024 earnings summary

Executive summary

• Achieved operating revenue of CNY 6.084 billion in 2024, up 8.55% year-over-year; net profit attributable to shareholders was CNY 921 million, up 1.19% year-over-year; net profit after non-recurring items was CNY 860 million, up 9.79% year-over-year; gross profit margin rose to 49.47%, up 1.41 percentage points year-over-year.

• Maintained strong competitive advantages in traditional fields, drove growth through innovation, digital transformation, and strategic M&A, and expanded international presence.

• Significant investments in R&D (CNY 529 million, 8.7% of revenue), digital transformation, and talent development supported sustainable growth.

Financial highlights

• Operating revenue: CNY 6,084,016,542.19 (up 8.55% year-over-year).

• Net profit attributable to shareholders: CNY 921,073,108.56 (up 1.19% year-over-year).

• Net profit after non-recurring items: CNY 860,428,668.83 (up 9.79% year-over-year).

• EBITDA: CNY 1,539,358,712.28 (up 1.20% year-over-year).

• Basic and diluted EPS: CNY 0.55.

• ROE: 14.07% (down 1.48 percentage points year-over-year).

• Total assets: CNY 9,452,604,079.86 (up 8.04% year-over-year).

• Net assets attributable to shareholders: CNY 6,913,388,893.02 (up 11.41% year-over-year).

• Cash dividend: CNY 1 per 10 shares.

Outlook and guidance

• Strategic focus on “123” strategy: stabilize traditional business, accelerate high-growth sectors, and incubate new business lines.

• Continued investment in digital transformation, AI, and lean management to drive efficiency and quality.

• Prudent but proactive M&A to expand international footprint and strengthen core capabilities.

• Commitment to sustainable development, ESG, and shareholder returns through consistent dividends and share repurchases.